Products - Ear, nose and throat conditions | Topic

Showing 12 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (TA1045)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
5 March 2025
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
6 August 2025
Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 September 2025
Benralizumab for previously treated severe nasal polyps [ID1659]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysphagia
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [TSID11918]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps [ID6449]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
AHEAD implants for external ear prosthesis
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Technologies to support home monitoring of vision change in macular disease
Status:
Awaiting development
Programme:
Health technology evaluation
Expected publication date:
TBC

Ear, nose and throat conditions Products

Filter

Product type
1 selected

Guidance programme

Status

New and updated
1 selected

Showing 12 products

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (TA1045)

Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462

Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]

Benralizumab for previously treated severe nasal polyps [ID1659]

Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysphagia

Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [TSID11918]

Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis

Depemokimab for treating chronic rhinosinusitis with nasal polyps [ID6449]

Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]

Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen in people 5 to 17 years [ID6537]

AHEAD implants for external ear prosthesis

Technologies to support home monitoring of vision change in macular disease

Ear, nose and throat conditions Products

Filter

Product type1 selected

Guidance programme

Status

New and updated1 selected

Showing 12 products

Product type
1 selected

New and updated
1 selected